90 related articles for article (PubMed ID: 16386581)
1. Initial immunosuppression in liver transplant recipients with impaired renal function.
Varo E; López A; Rivero C
Transplant Proc; 2005 Nov; 37(9):3909-12. PubMed ID: 16386581
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
[TBL] [Abstract][Full Text] [Related]
3. [Immunosuppression in liver transplantation: renoprotective regimens].
Serrano Aulló MT; Parra Moncasi E; Lorente Pérez S
Gastroenterol Hepatol; 2011; 34(6):422-7. PubMed ID: 21458889
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
5. Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: The role of extracorporeal photopheresis.
Urbani L; Mazzoni A; De Simone P; Catalano G; Coletti L; Petruccelli S; Biancofiore G; Bindi L; Scatena F; Filipponi F
J Clin Apher; 2007; 22(4):187-94. PubMed ID: 17294458
[TBL] [Abstract][Full Text] [Related]
6. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
9. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
De Simone P; Metselaar HJ; Fischer L; Dumortier J; Boudjema K; Hardwigsen J; Rostaing L; De Carlis L; Saliba F; Nevens F
Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150
[TBL] [Abstract][Full Text] [Related]
10. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
Bajjoka I; Hsaiky L; Brown K; Abouljoud M
Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M
Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600
[TBL] [Abstract][Full Text] [Related]
12. Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients.
Morard I; Dumortier J; Spahr L; Hadengue A; Majno P; Morel P; Mentha G; Giostra E
Liver Transpl; 2007 May; 13(5):658-64. PubMed ID: 17457887
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
Guerra G; Srinivas TR; Meier-Kriesche HU
Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
[TBL] [Abstract][Full Text] [Related]
14. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
[TBL] [Abstract][Full Text] [Related]
15. Chronic renal dysfunction following liver transplantation.
Schmitz V; Laudi S; Moeckel F; Puhl G; Stockmann M; Tran ZV; Kahl A; Neumann U; Neuhaus P
Clin Transplant; 2008; 22(3):333-40. PubMed ID: 18341597
[TBL] [Abstract][Full Text] [Related]
16. Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors.
San Segundo D; Fábrega E; López-Hoyos M; Pons F
Transplant Proc; 2007 Sep; 39(7):2290-2. PubMed ID: 17889166
[TBL] [Abstract][Full Text] [Related]
17. [Current trends in renal transplant immunosuppression].
Kes P; Basić-Jukić N
Acta Med Croatica; 2006 Jun; 60(3):243-9. PubMed ID: 16933837
[TBL] [Abstract][Full Text] [Related]
18. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
[TBL] [Abstract][Full Text] [Related]
19. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
[TBL] [Abstract][Full Text] [Related]
20. Kidney dysfunction in the recipients of liver transplants.
Wilkinson A; Pham PT
Liver Transpl; 2005 Nov; (11 Suppl 2):S47-51. PubMed ID: 16237714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]